Decreasing severe pain and serious adverse events while moving intensive care unit patients: a prospective interventional study (the NURSE-DO project)

Table 4 Incidence of serious adverse events during each phase of the study

	Phase 1 (baseline) n= 182	Phase 2 (intervention) n= 129	Phase 3 (adjustment) n= 170	Phase 4 (consolidation) n= 149	P 1-2	P 1-3	P 1-4
Cardiac arrest, n (%)	2 (1%)	0 (0%)	0 (0%)	0 (0%)
Arrhythmias, n (%)	3 (2%)	4 (3%)	1 (1%)	0 (0%)
Tachycardia, n (%)	5 (3%)	5 (4%)	3 (2%)	6 (4%)
Bradycardia, n (%)	0 (0%)	2 (2%)	0 (0%)	0 (0%)
Hypertension, n (%)	14 (8%)	2 (2%)	6 (4%)	11 (7%)
Hypotension, n (%)	8 (4%)	5 (4%)	2 (1%)	9 (6%)
Oxygen desaturation, n (%)	19 (10%)	15 (12%)	8 (5%)	6 (4%)
Bradypnea, n (%)	2 (1%)	6 (5%)	0 (0%)	0 (0%)
Ventilatory distress, n (%)	24 (13%)	13 (10%)	15 (9%)	2 (1%)
At least one event, n (%)	68 (37%)	36 (28%)	29 (17%)	31 (21%)	0.09	< 0.001	0.005

Statistical analysis was performed using a generalized linear mixed-effects model for repeated measures.

ISSN: 1364-8535